Healthy Growth Starts Here
Frost & Sullivan’s Transformational Health practice has a powerhouse team of analysts and strategists covering all facets of this trillion-dollar industry.
We analyze growth opportunities and competitive positioning for our clients, based on our years of expertise, combined with the voice of the customer, to identify the best strategies to succeed in a world where disruptions are occurring due to Care Delivery Transformation, Site of Care Evolution, Payment Transition to Value-based Care, New Market Entrants, Business Model Innovation and Cutting-edge Technologies.
Our Growth Opportunity Newsletter
Book a complimentary one-hour session of Growth Strategy Dialog with our experts.
Upcoming speaking engagements
Healthcare systems are undergoing dramatic structural changes that will impact every aspect of the way healthcare services are paid for and delivered, and the movement of care outside traditional settings is transforming medicine through digital health solutions.
Advanced Medical Technologies
In-depth coverage of the multitude of products and solutions used by providers across a typical clinical pathway, ranging from making a diagnosis, using the appropriate interventional or therapeutic approach and finally monitoring the subject through rehabilitation and convalescence.
To achieve continued double digit growth and mitigate risks in R&D and manufacturing, pharma companies must gather actionable intelligence that will enable them to move rapidly from quantity-based, fee-for-service model to outcomes based contracts and adopt new digital platforms.
Clinical Diagnostics & Research Tools
The industry is witnessing significant disruptions around new regulations (PAMA implementation, deployment of laboratory developed tests) and move towards decentralized testing (home & retail type settings).
Critical Trends for Healthcare Transformation
Business Models & Services
Diminishing returns on investments made towards strategies for technical innovation, are putting pressure on healthcare companies to achieve growth objectives through radically evolving their business model.
Health Data Science
Future of Industries & Outlooks
Medical Technology Disruptors
From Hospital to Home
New Technology Adoption
News, Events & Resources
As the biologics Contract Development and Manufacturing Organization (CDMO) market expands at double-digit rates, Thermo Fisher Scientific (TMO) is doubling down on its portfolio again, after acquiring Henogen SA (viral vector manufacturer) and Mesa Biotech, Inc...
Hospital at Home Care Set to Make it Big in the United States with Strong Support from the Government
Adoption of HaH model surged eight-fold in less than six months with the availability of advanced remote monitoring and digital health solutions, finds Frost & Sullivan Santa Clara, Calif. –April 12, 2021–Frost & Sullivan’s recent analysis, Payment Reforms and...
AI-Based Imaging Analysis Tools and Cloud-Based Deployments to Bolster the Global Digital Pathology Market
Storage solutions segment to register the highest growth, followed by software solutions and hardware solutions, finds Frost & Sullivan Santa Clara, Calif. –April 5, 2021–Frost & Sullivan’s recent analysis, AI-Based Image Analysis Tools and Cloud-Based...